MedTrace Logo

Screening for NAFLD in Flanders

NCT04647409 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10000

Last updated 2025-12-01

No results posted yet for this study

Summary

In the Belgian adult population more than half, and numbers are still increasing, of the population is overweight or obese. These people are at risk to develop NAFLD. However, we lack epidemiological data in Belgium. Therefore, it is important to do epidemiological studies to investigate NAFLD prevalence and disease severity based on a non-invasive approach and evaluate how patients are to be referred.

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

OTHER

screening

The determination of the prevalence of NAFLD in a general population in Flanders, Belgium

Sponsors & Collaborators

  • Hasselt University

    lead OTHER

Principal Investigators

  • Geert Robaeys, prof. dr. · Hasselt University

  • Leen Heyens, drs. · Hasselt University

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-26
Primary Completion
2025-04-30
Completion
2026-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04647409 on ClinicalTrials.gov